160 related articles for article (PubMed ID: 17336323)
1. A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17.
Chiriva-Internati M; Grizzi F; Weidanz JA; Ferrari R; Yuefei Y; Velez B; Shearer MH; Lowe DB; Frezza EE; Cobos E; Kast WM; Kennedy RC
J Immunol Methods; 2007 Apr; 321(1-2):86-93. PubMed ID: 17336323
[TBL] [Abstract][Full Text] [Related]
2. [Aberrant expression of sperm protein 17 enhances migration of ovarian cancer cell line HO-8910].
Liu Q; Li FQ; Han YL; Wang LK; Hou YY
Zhonghua Nan Ke Xue; 2008 Nov; 14(11):982-6. PubMed ID: 19102497
[TBL] [Abstract][Full Text] [Related]
3. Tumor vaccine for ovarian carcinoma targeting sperm protein 17.
Chiriva-Internati M; Wang Z; Salati E; Timmins P; Lim SH
Cancer; 2002 May; 94(9):2447-53. PubMed ID: 12015770
[TBL] [Abstract][Full Text] [Related]
4. Sperm protein 17 is a suitable target for adoptive T-cell-based immunotherapy in human ovarian cancer.
Chiriva-Internati M; Weidanz JA; Yu Y; Frezza EE; Jenkins MR; Kennedy RC; Cobos E; Kast WM
J Immunother; 2008 Oct; 31(8):693-703. PubMed ID: 18779750
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
[TBL] [Abstract][Full Text] [Related]
6. [Biological characteristics of an established model of ovarian cancer in mice and its homologous cell lines].
Zhang ZM; Zhang C; Zhang FH; Shan BE; Nakagawa S
Ai Zheng; 2006 Jun; 25(6):701-7. PubMed ID: 16764764
[TBL] [Abstract][Full Text] [Related]
7. S100A4 expression with reduced E-cadherin expression predicts distant metastasis of human malignant melanoma cell lines in the NOD/SCID/gammaCnull (NOG) mouse model.
Ikoma N; Yamazaki H; Abe Y; Oida Y; Ohnishi Y; Suemizu H; Matsumoto H; Matsuyama T; Ohta Y; Ozawa A; Ueyama Y; Nakamura M
Oncol Rep; 2005 Sep; 14(3):633-7. PubMed ID: 16077966
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an ovarian metastasis model and possible involvement of E-cadherin down-regulation in the metastasis.
Kuwabara Y; Yamada T; Yamazaki K; Du WL; Banno K; Aoki D; Sakamoto M
Cancer Sci; 2008 Oct; 99(10):1933-9. PubMed ID: 19016752
[TBL] [Abstract][Full Text] [Related]
9. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer.
Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A
Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284
[TBL] [Abstract][Full Text] [Related]
10. Orthotopically implanted SCID mouse model of human lung cancer suitable for investigating metastatic potential and anticancer drug effects.
Kondo K; Fujino H; Miyoshi T; Ishikura H; Sakiyama S; Monden Y
Oncol Rep; 2004 Nov; 12(5):991-9. PubMed ID: 15492783
[TBL] [Abstract][Full Text] [Related]
11. Adenylate kinase-4 is a marker of poor clinical outcomes that promotes metastasis of lung cancer by downregulating the transcription factor ATF3.
Jan YH; Tsai HY; Yang CJ; Huang MS; Yang YF; Lai TC; Lee CH; Jeng YM; Huang CY; Su JL; Chuang YJ; Hsiao M
Cancer Res; 2012 Oct; 72(19):5119-29. PubMed ID: 23002211
[TBL] [Abstract][Full Text] [Related]
12. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS analysis of ovarian cancer metastasis-related proteins using a nude mouse model: 14-3-3 zeta as a candidate biomarker.
He Y; Wu X; Liu X; Yan G; Xu C
J Proteome Res; 2010 Dec; 9(12):6180-90. PubMed ID: 21028892
[TBL] [Abstract][Full Text] [Related]
14. RNA interference-mediated silencing of the phosphatidylinositol 3-kinase catalytic subunit attenuates growth of human ovarian cancer cells in vitroand in vivo.
Zhang X; Deng HX; Zhao X; Su D; Chen XC; Chen LJ; Wei YQ; Zhong Q; Li ZY; He X; Yi T
Oncology; 2009; 77(1):22-32. PubMed ID: 19440000
[TBL] [Abstract][Full Text] [Related]
15. Transplantation of human acute myeloid leukemia (AML) cells in immunodeficient mice reveals altered cell surface phenotypes and expression of human endothelial markers.
Henschler R; Göttig S; Junghahn I; Bug G; Seifried E; Müller AM; Fichtner I
Leuk Res; 2005 Oct; 29(10):1191-9. PubMed ID: 15941586
[TBL] [Abstract][Full Text] [Related]
16. Tumor promoting properties of the ETS protein MEF in ovarian cancer.
Yao JJ; Liu Y; Lacorazza HD; Soslow RA; Scandura JM; Nimer SD; Hedvat CV
Oncogene; 2007 Jun; 26(27):4032-7. PubMed ID: 17213815
[TBL] [Abstract][Full Text] [Related]
17. Systematic antigenic profiling of hematopoietic antigens on ovarian carcinoma cells identifies membrane proteins for targeted therapy development.
Helpman L; Katz BZ; Safra T; Schreiber L; Levine Z; Nemzer S; Kinar Y; Grisaru D
Am J Obstet Gynecol; 2009 Aug; 201(2):196.e1-7. PubMed ID: 19646570
[TBL] [Abstract][Full Text] [Related]
18. A Nod Scid mouse model to study human prostate cancer.
Bastide C; Bagnis C; Mannoni P; Hassoun J; Bladou F
Prostate Cancer Prostatic Dis; 2002; 5(4):311-5. PubMed ID: 12627217
[TBL] [Abstract][Full Text] [Related]
19. Relations among expression of CXCR4, histological patterns, and metastatic potential in adenoid cystic carcinoma of the head and neck.
Zushi Y; Noguchi K; Hashitani S; Sakurai K; Segawa E; Takaoka K; Toyohara Y; Tanaka N; Kishimoto H; Urade M
Int J Oncol; 2008 Dec; 33(6):1133-9. PubMed ID: 19020745
[TBL] [Abstract][Full Text] [Related]
20. Expression of sperm protein 17 (Sp17) in ovarian cancer.
Straughn JM; Shaw DR; Guerrero A; Bhoola SM; Racelis A; Wang Z; Chiriva-Internati M; Grizzle WE; Alvarez RD; Lim SH; Strong TV
Int J Cancer; 2004 Mar; 108(6):805-11. PubMed ID: 14712480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
